Thyrocare Technologies Limited

Thyrocare Technologies Limited (THYROCARE) is a small-cap Healthcare company valued at ₹7,737 crore operating in Healthcare Service Provider on the NSE and BSE.

Recent price move

Thyrocare Technologies Limited last traded at ₹485.5, modestly down 0.42% on the day.

Recent developments

On 2026-09-21, Thyrocare announced an acquisition agreement and the purchase of compulsorily convertible preference shares as part of a deal. On 2026-08-13, the promoter sold a 9.90% stake following a pledge release, causing the stock to drop 8%.

Financial performance

The company's business is improving, with annual revenue rising 20.7% and annual net profit surging 79.0%. The latest quarter saw revenue and net profit grow 24.4% and 35.1% respectively compared to the same quarter a year earlier. The net profit margin widened to 19.6% from 13.2% a year ago, while return on equity remained at 27.8%.

Valuation multiples

The stock trades at 47.3 times earnings, a premium to the Healthcare median of 32.0, 17.30 times book value. It yields 2.5%.

Things to watch

The promoter's holding fell by 9.90 percentage points in the quarter, raising concerns about control. The stock is 26.7% below its 52-week high, indicating a significant pullback from recent peak levels. The promoter's stake sale triggered a sharp decline in the share price.

Where it stands

Thyrocare Technologies has delivered strong revenue and profit growth, with the latest quarter showing robust expansion. The promoter's stake sale and the stock's distance from its 52-week high are the most significant factors currently. The company's financials remain healthy with low debt and improving margins.

Summarised by DocStoX's model on 2026-10-17 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.